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Abstract
The GABA-B receptor is densely expressed throughout the brain and has been implicated in many CNS functions and
disorders, including addiction, epilepsy, spasticity, schizophrenia, anxiety, cognitive deficits, and depression, as well
as various aspects of nervous system development. How oneGABA-B receptor is involved in somany aspects of CNS
function remains unanswered. Activation of GABA-B receptors is normally thought to produce inhibitory responses in
the nervous system, but puzzling contradictory responses exist. Here we report that in rat mitral cells of the olfactory
bulb, GABA-B receptor activation inhibits both the persistent sodium current (INaP) and the sodium-activated
potassium current (IKNa), which is coupled to it. We find that the primary effect of GABA-B activation is to inhibit INaP,
which has the secondary effect of inhibiting IKNa because of its dependence on persistent sodium entry for activation.
This can have either a net excitatory or inhibitory effect depending on the balance of INaP/IKNa currents in neurons. In
the olfactory bulb, the cell bodies of mitral cells are densely packed with sodium-activated potassium channels. These
channels produce a large IKNa which, if constitutively active, would shunt any synaptic potentials traversing the soma
before reaching the spike initiation zone. However, GABA-B receptor activation might have the net effect of reducing
the IKNa blocking effect, thus enhancing the effectiveness of synaptic potentials.
Key words: Baclofen; GABA-B; olfactory bulb; persistent sodium current; potassium channel; SLO2; mitral
cell; Slick
Introduction
-Amino butyric acid (GABA) is the major inhibitory
neurotransmitter in the CNS. Two major classes of pro-
teins are known that mediate GABA responses: the iono-
tropic GABA-A receptor family (a chloride ion channel)
and the metabotropic GABA-B receptor. The GABA-B
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Significance Statement
The GABA-B receptor is densely expressed in the brain and implicated in many CNS functions and
disorders, but knowledge of its mode of action is limited. We have found a novel action whereby GABA-B
receptor activity inhibits two opposing currents, the persistent sodium current and the sodium-activated
potassium current that is activated by it. It is likely that GABA-B receptor activation through this coupled
system of currents can have either a net excitatory or inhibitory response depending on the balance of
currents. Extensive colocalization of GABA-B receptors and sodium-activated potassium channels through-
out the nervous system suggests a significant mechanism for GABA-B neuromodulation, and our results
suggests new insights for controlling cell excitability through GABA-B modulators.
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receptor is not a channel itself, but a G protein–coupled
receptor (GPCR) that regulates various ion channels and
other functions by G protein signaling. The GABA-B re-
ceptor has been implicated in many CNS functions and
disorders (Bettler et al., 2004) and is also involved in
various aspects of nervous system development (Prosser
et al., 2001; Schuler et al., 2001). How this single GABA-B
receptor induces so many varied downstream functions
remains a major unanswered question. There are currently
two well-characterized ion channel targets responsive to
GABA-B signals: N-type calcium channels, which are typ-
ically presynaptic and inhibited by GABA-B signaling, and
the GIRK family of inward-rectifying potassium channels,
which are typically postsynaptic and activated by
GABA-B signaling (Bettler et al., 2004). Both actions have
a net inhibitory effect. However, unexplained contradic-
tory excitable responses are also present that greatly limit
the clinical usefulness of GABA-B activators such as
baclofen (Vergnes et al., 1997; Bowery, 2006).
We now report a novel effect of GABA-B signaling on
the INaP/IKNa coupled system. We recently reported the
existence of this unusual system in which persistent so-
dium current (INaP) activates high-conductance sodium-
activated potassium currents (IKNa; Budelli et al., 2009;
Hage and Salkoff, 2012). The components of this coupled
system are widely distributed throughout the brain (Dryer,
1994; Kaczmarek, 2013) and control the electrical excit-
ability of various neuronal types (Dryer, 1994; Bhattacha-
rjee and Kaczmarek, 2005). INaP enhances neuronal
excitability, and blocking INaP (without blocking the
transient sodium current) is a common strategy used in
designing pharmacological agents to prevent seizures
(Rogawski and Loscher, 2004; Mantegazza et al., 2010).
However, our results showed an unanticipated role for
INaP in activating sodium-activated potassium currents
which act as a negative feedback system in countering its
own excitable effects. Whether these two interacting cur-
rents have a net excitable or inhibitory effect depends on
the amplitudes and balance of these two currents in a
particular neuronal type. Our results now show that acti-
vation of the GABA-B pathway reduces both of these
currents, INaP directly and IKNa indirectly as a secondary
consequence of inhibiting the Na entry pathway that
activates it.
This mechanism of GABA-B action may interface with
other functions of GABA-B even in the same cell types. In
the mammalian olfactory bulb, GABA-B receptors are
present on the lateral dendrites and cell bodies of mitral
cells. GABA is released at these sites from the synapses
of dendrites of associated granule cells. These two cell types
undergo complex dendrodendritic interactions which may
involve several mechanisms of GABAergic signaling (Isaac-
son and Vitten, 2003).
Materials and Methods
Primary neuronal culture preparations
Primary cultures of dissociated olfactory bulbs of neonatal
Sprague-Dawley rats of either sex were prepared following
methods described previously (Trombley and Westbrook,
1990). In brief, dissected olfactory bulbs were incubated
in 0.25% trypsin in PBS for 30 min at 37°C. For the last 5
min, trypsin solution was supplemented with 0.05%
DNase. Cells were then triturated and plated on poly-
lysine–coated glass coverslips in Dulbecco’s modified
Eagle medium/F-12 media (Gibco) with 10% FBS and 2%
B-27 supplement (Gibco). 3 d after plating, media was
replaced with Neurobasal (Gibco) 2% B-27 supplement
and 5 M arabinofuranosyl cytidine to inhibit division of
glia. Whole-cell recordings were performed 3–6 d after
plating.
Primary neuronal culture immunostaining
Olfactory bulb neurons were cultured on 12-mm-diameter
coverslips for 10–14 d in vitro. Cells were fixed with 4%
paraformaldehyde in PBS for 15 min at 4°C and stored in
PBS at 4°C for future use. Cells were incubated for 1 h in
blocking solution [Tris-buffered saline (TBS) with 2% fetal
bovine serum (Invitrogen)]. Cells were permeabilized with
0.2% saponin (Sigma-Aldrich) in TBS for 15 min at room
temperature. Primary antibody incubations (2 g/ml in
blocking buffer) were performed either for 1 h at room
temperature or overnight at 4°C; cells were washed for at
least 30 min at room temperature with TBS. Secondary
antibodies were incubated for 1 h at room temperature in
blocking buffer, then washed as above. Cells were stained
with Hoechst 33258 (Sigma-Aldrich) to identify nuclei and
mounted on microscope slides in Fluoro-shield (Sigma-
Aldrich). Cells were observed with a Nikon Eclipse E800
microscope and a 60 oil-immersion objective and im-
aged with a CoolSnap EZ CCD camera and Qcapture
(QImaging). Only images from mitral/tufted cells (large
neurons with a pyramidal morphology) are shown. SLO2.1
and NaV 1.6 immunostaining was abolished by preincu-
bation with the antigenic peptide for 1 h at room temper-
ature. The two different antibodies to SLO2.1 (also known
as Slick) both produce highly similar results. Representa-
tive images from at least three separate neuronal prepa-
rations produced similar results.
Primary antibodies were purchased from the following
sources: rabbit anti-NaV 1.6 (AB5580, EMD Millipore,
1:1000, RRID:AB_91916); rabbit anti-Slick (APC-126, Alo-
mone labs, 1:500, RRID: AB_10613114); mouse anti-Slick
(73-055, clone N11/33, NeuroMabs, 1:50, Antibody Registry
AB_10675450); mouse anti-GABAB-R1 (73-183, clone N93A/
49, NeuroMabs, 1:50, Antibody Registry AB_10672843).
Fluorophore-coupled anti–mouse IgG and anti–rabbit IgG
secondary antibodies were purchased from Sigma-Aldrich.
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Xenopus oocytes injection
Xenopus laevis oocytes were injected with 50 nl cRNA
(1–3 g/l) using a Drummond Scientific nanoinjector.
Injected oocytes were incubated at 18°C in ND96 medium
(inmM): 96 NaCl, 2 KCl, 1.8 CaCl2, 1MgCl2, and 5 HEPES, pH
7.5, with NaOH. Electrophysiology experiments on
oocytes were undertaken 3–5 d after injection.
Voltage-clamp recordings and analysis
Tufted/mitral cells were identified on the basis of their
pyramidal shape and large size. Voltage-clamp record-
ings were performed using an Axopatch 200B amplifier
(Molecular Devices). Recordings were filtered at 2 kHz
with the internal filter of the amplifier and digitized at 10
kHz using a Digidata 1322A digitizer (Molecular Devices).
Recording pipettes were pulled from borosilicate glass
with tip resistances of 3–5 M after filling with internal
pipette solution contained (in mM): 140 KCl, 1 MgCl2, 10
HEPES, and 5 EGTA, pH 7.3, with KOH. Bath solutions
contained (in mM): 150 NaCl, 5 KCl, 2 MgCl2, 10 HEPES,
and 10 glucose, pH 7.3, with NaOH. For slow-ramp pro-
tocol recordings, the internal solution contained (in mM):
140 KMES, 1 MgCl2, 10 HEPES, and 5 EGTA, pH 7.3, with
KOH. Tetrodotoxin (TTX), baclofen, and GABA were used
at 0.2, 10, or 100 M for 3 min before recording.
Two-electrode voltage-clamp experiments in Xenopus
oocytes injected with SlO2.1 cRNA were undertaken in
ND96 plus 1–2 mM DIDS to block the endogenous chlo-
ride conductances. Voltage steps (80 to 40 mV) were
applied in 10-mV increments from a holding potential of
70 mV. Recording pipettes were filled with 3 M KCl.
Baclofen was applied to the recording chamber by contin-
uous perfusion. TTX, baclofen, and GABA were prepared
daily from 3-, 5-, or 500-mM stock solutions (in ddH2O). All
chemicals were purchased from Sigma-Aldrich.
Whole-cell recordings were acquired and analyzed with
pClamp 9.0 (Molecular Devices). Statistical analysis was
performed using previously described tools (Budelli et al.,
2009; Hage and Salkoff, 2012). For comparison of results
between two groups, paired Student’s t tests were used
for the same procedures before and after applied treat-
ments. One-way ANOVA was used to determine whether
there were statistically significant differences among the
effects of the three drugs (TTX, baclofen, and GABA).
Results
Mitral cells, the main output neurons of the olfactory
bulb, are known to express a large component of sodium-
activated potassium current (IKNa) (Egan et al., 1992a, b;
Bhattacharjee and Kaczmarek, 2005). We previously
showed that IKNa is activated by sodium entry through the
persistent current component of voltage-dependent so-
dium channels (Hage and Salkoff, 2012). As with the
transient component of sodium current, the persistent
current component can also be blocked by the sodium
channel blocker TTX. Application of TTX to a voltage-
clamped neuron results in the removal of a large non-
inactivating outward current corresponding to IKNa (Fig.
1A). To support the hypothesis that the TTX-sensitive
outward current is a sodium-dependent current, we pro-
duced virtually identical results by replacing extracellular
sodium ion with either choline or lithium ion (Budelli et al.,
2009). Both techniques removed the same outward cur-
rent component. Our previous study also revealed that a
similar sodium-dependent outward current is present in
several neuronal types and that the current is carried by
the SLO2 family of high-conductance potassium channels
(Budelli et al., 2009; Hage and Salkoff, 2012). The removal
of this outward current by blocking sodium channels or by
eliminating sodium ions showed that it was being re-
moved as a secondary consequence of the elimination of
a sodium current; we showed this to be the persistent
component of the sodium current (Hage and Salkoff,
2012). Fig. 1A shows whole-cell currents recorded from a
cultured rat mitral cell before (top traces) and after (middle
traces) application of 0.2 M TTX. After application of
TTX, the reduction in outward current at 40 mV was 26.8 
2.4% (n  12, p 	 0.0001). The TTX-sensitive IKNa, which
decays only slightly over a time course of a second, is
revealed by subtraction of TTX-resistant current from con-
trol current (bottom traces). The bottom panel of Fig. 1A
shows the current–voltage relationship of the TTX-
sensitive current. It should be noted that there is an
inward current component (arrow) preceding the outward
current in this TTX-sensitive I-V plot. Previously we
showed that this inward component represents a TTX-
sensitive persistent sodium current that is active over a
wide voltage range (Hage and Salkoff, 2012). Note that
the inward currents indicated by arrows in the bottom
panels of Fig. 1 represent steady-state persistent currents
that were plotted at a time point long after the inactivation
of the transient component of sodium conductance (see
legend). However, both the transient and persistent com-
ponents of sodium current in mitral cells are blocked by
TTX (Hage and Salkoff, 2012).
Neuromodulation of sodium-activated K currents in
native cells
One distinguishing structural feature of SLO2 channels
that carry the sodium-activated K current is the absence
of a string of positively charged amino acids in the S4
trans-membrane domain that are critical for voltage sens-
ing (Santi et al., 2006). As a consequence, SLO2 family
channels lack the property of acute voltage sensitivity
found in many voltage-activated ion channels carrying
these conserved positive charges. Considering the weak
voltage sensitivity of SLO2 family channels, we reasoned
that these channels might be controlled in ways in addi-
tion to voltage and investigated the possibility of their
being controlled by metabotropic neuromodulators (Santi
et al., 2006). In that study, we showed that SLO2 family
channels expressed in Xenopus oocytes can be modu-
lated by several neuromodulators acting through coex-
pressed G protein–coupled receptors (GPCRs). Because
those experiments were undertaken in a heterologous
expression system coexpressing SLO2 channels and
GPCRs from different sources, and not native neurons
(Santi et al., 2006), we commenced a study to determine
which GPCRs might be present in native rat mitral cells,
which are known to express high levels of sodium-activated
potassium channels (Egan et al., 1992a, b; Bhattacharjee
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and Kaczmarek, 2005). Thus, we undertook a series of
immunocytology experiments as well as gleaned relevant
information from the Allen Brain Atlas and the literature.
These studies revealed that GABA-B GPCRs are ex-
pressed at a conspicuously high density on the soma of
mitral cells (Fig. 2B, E). We also showed that GABA-B
receptors are coexpressed with the Na-activated K
channel, SLO2.1, as well as voltage-gated TTX-sensitive
sodium channels known to conduct both persistent and
transient components of the sodium current (Fig. 2D, G).
Because of the abundant presence of GABA-B receptors
in a cell type known to have robust expression of SLO2.1
channels (Panzanelli et al., 2004), we undertook experi-
ments to investigate whether the IKNa current could be
modulated by GABA-B receptors. Remarkably, applica-
tion of baclofen, a specific GABA-B activator (Bowery,
2006), to voltage-clamped rat mitral cells produced a
change in whole-cell currents that is virtually identical to
the change produced by TTX application. As shown in Fig
1B, a large component of delayed non-inactivating out-
ward current was removed after application of 10 M
baclofen [the outward current reduction at 40 mV was
30.4  2.5% (n  12, p 	 0.0001)], along with what
appeared to be the persistent sodium current (Fig. 1B, bot-
tom panel, arrow). Thus, activation of GABA-B receptors
appear to inhibit the coupled system of INaP and IKNa in a
manner highly similar to that of TTX, where the primary effect
appears to be on the inhibition of the persistent sodium
current, which leads to a secondary effect, the inhibition of
the sodium-dependent outward current.
Baclofen and GABA evoke similar effects
As a further check to verify that the observed action of
baclofen is on GABA-B receptors and not due to an
off-target effect, we examined the effect of GABA on
whole-cell currents of rat mitral cells. Whereas baclofen is
highly selective for GABA-B receptors, GABA activates
both ionotropic GABA-A and GABA-B receptors. Never-
theless, we should be able to duplicate the effect of
baclofen in this experiment if we can subtract out any
current components elicited through GABA-A, while view-
ing the remaining GABA-B effects. The first notable effect
Figure 1. TTX, baclofen, and GABA all inhibit inward and outward currents. Representative traces of whole-cell currents recorded
from cultured rat mitral cells in the absence and presence of 0.2 M TTX (A), 10 M baclofen (B), or 100 M GABA (C). The top traces
show the control currents evoked from a holding potential of –70 mV in steps from –80 to 60 mV in 10-mV intervals. The middle traces
show the residual currents after application of TTX (A), baclofen (B), or GABA (C). The bottom traces show TTX-sensitive (A),
baclofen-sensitive (B), or GABA-sensitive (C) current that is obtained by subtraction of the residual current (after drug application)
from the control current (before drug application). After application of TTX, baclofen, or GABA, the outward current reduction at 40
mV was 26.8  2.4% (n  12, p 	 0.0001), 30.4  2.5% (n  12, p 	 0.0001), or 22.9  2.1% (n  5, p 	 0.0001), respectively. The
I-V plot determined from steady-state values of drug-sensitive current is given below each group of sample traces. The removed
inward component of current is indicated by an arrow. Note that the current/voltage plots below the current traces indicate steady
state current measured250 ms after the initiation of the step pulses. Because of the overlap of rapidly activating inward and outward
currents at the initiation of the step pulses, the currents shown in the first few milliseconds of the traces may not be an accurate
depiction of their kinetic properties.
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of adding GABA was the appearance of a large membrane
leak component, ostensibly due to the activation of
GABA-A receptors. The subtraction of the GABA-A cur-
rent component turned out to be possible because it
resembled a linear steady-state leak component. Thus,
after subtracting this large leak component from the re-
corded current, the remaining current and its subtracted
component were remarkably similar to that seen after the
application of baclofen (Fig. 1C). After application of 100
M GABA, the outward current reduction at 40 mV was
22.9  2.1% (n  5, p 	 0.0001). This result provides
further support that the effect of baclofen on the whole-
cell current of mitral cells is specifically through the
GABA-B receptors. One-way ANOVA was performed on
the effects of TTX, baclofen, and GABA, and no significant
difference was found (p 
 0.05).
GABA-B activation targets the persistent sodium
current
Because the results with baclofen so closely mirrored
the results with TTX, we reasoned that the direct effect of
baclofen was to eliminate the persistent sodium current,
whereas a secondary indirect effect was to eliminate the
sodium-dependent outward current. To more clearly ob-
serve this hypothesized primary effect of baclofen on the
persistent sodium current, we used a slow-ramp voltage-
clamp protocol to directly observe the persistent sodium
current uncontaminated by the transient component of
sodium current (Estacion and Waxman, 2013). In addition,
we applied quinidine, a K channel blocker, to remove a
portion of outward current to more clearly reveal the
persistent sodium current. The results are shown in Fig. 3.
Using this slow-ramp protocol in the presence of quini-
dine, we examined the effects of TTX, baclofen, or GABA
on the inward current component from rat mitral cells. As
shown in Fig. 3C, the inward current component is sen-
sitive to each of these three agents and is remarkably
similar in various properties including amplitude, kinetics,
and voltage range of activation. Note that the earlier and
smaller of two components of inward current present in
some traces may be an early “window” component that is
dependent on closed-state inactivation. The second and
larger component at more depolarized potentials is the
persistent sodium current that is detected for many tens
of milliseconds after the start of a depolarizing pulse
(Estacion and Waxman, 2013). To further illustrate the
similarity between the inward currents eliminated by TTX
and baclofen, we averaged together the persistent cur-
rents obtained from six neurons exposed to TTX and six
exposed to baclofen and overlapped the traces as shown
in Fig. 3D. The virtual identity of the two currents com-
pared in this way is striking (see legend for quantitative
data). It is known that more than one voltage-gated so-
dium channel (VGSC) type is expressed in olfactory mitral
cells (Krzemien et al., 2000; Schaller and Caldwell, 2000),
and most VGSCs can express small amounts of persistent
sodium current. Although it is conceivable that their sen-
sitivities to either TTX or baclofen may differ, the similar-
ities of the overlapped traces shown in Fig. 3D suggest
that the same current components are being removed by
both agents. Prior treatment with TTX effectively elimi-
nates the effect of baclofen (Fig. 3E, 4.3  2.1%, n  4,
p 
 0.05) and vice versa (Fig. 3F, 2.2  1.0%, n  5, p 

0.05), also indicating that both agents reduce the same
Figure 2. The GABA-B receptor (GABAB-R1) colocalizes with sodium-activated potassium channels (SLO2.1) and voltage-sensitive
sodium channels (NaV1.6). Rat olfactory bulb primary neurons were immunostained with pairwise combinations of primary antibodies
(indicated at top left) raised from different species, followed by staining with fluorophore-coupled secondary antibodies. Panels c, f,
and i are merged images, demonstrating that both proteins are present in the same cell. As with other channels and receptors, there
is likely an intracellular pool as well a cell-surface pool, consistent with previous results (Panzanelli et al., 2004). Control samples
incubated without any primary antibody show negligible staining (panels j, k, and l). The last column shows additional examples of
immunostaining for SLO2.1 or NaV 1.6 in the absence or presence of the antigenic peptide (panelsm, n, o, and p); the immunostaining
is dramatically reduced in the presence of the peptide. Scale bar in p: 5 m.
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current component. In a previous study observing single-
channel sodium currents in mitral cells, we showed that
the TTX-sensitive persistent current in these cells was due
to the reopenings of voltage-sensitive sodium channels
after the inactivation of the fast transient sodium current
component (Hage and Salkoff, 2012). Thus, like the effect
of TTX on these neurons in which the elimination of the
outward component of current is a secondary effect
caused by the primary effect of eliminating the persistent
sodium current (Budelli et al., 2009; Hage and Salkoff,
2012), the neuromodulatory effect of GABA-B stimulation
appears to primarily be reducing the persistent sodium
current. As will be discussed, we presume that TTX di-
rectly interacts with and blocks the sodium channels,
whereas baclofen or GABA acts though the GPCR signal-
ing cascade to block the sodium channels.
Baclofen has no direct effect on IKNa
Fig. 4A shows an example of whole-cell currents of SLO2.1
channels expressed in Xenopus oocytes before (control) and
after (baclofen) the addition of baclofen. After application of
10 M baclofen, the outward current at 40 mV was un-
changed compared with the control (Fig. 4B, C, n  5, p 

0.05). These data further support that inhibition of IKNa by
baclofen is secondary to the suppression of persistent so-
dium current, and that baclofen has no direct effect on IKNa.
Discussion
What is the functional significance of GABA-B
modulation of the INaP/IKNa system?
The absence of a canonical voltage sensor in the SLO2
channels that carry the sodium-activated K current re-
Figure 3. Similar persistent inward currents are inhibited by TTX, baclofen, and GABA. The top panels show examples of whole-cell
ramp currents recorded from cultured rat mitral cells in the absence (black) and presence (red) of 20 M quinidine. A slow ramp
protocol from a holding potential of –70 mV to 10 mV in 600 ms was applied. The blue traces shown in the middle panel are the ramp
currents recorded from the same cells after addition of 0.2 M TTX (A), 10 M baclofen (B), or 100 M GABA (C). The traces below
show the inward current components removed by TTX (A), baclofen (B), and GABA (C) obtained by subtraction of blue from red traces
in the panels above. Na and Ca2 were absent in the intracellular pipette solution, and Ca2 was absent in the extracellular recording
solutions. D, Averaged TTX-sensitive (blue) and baclofen-sensitive (red) ramp current traces from normalized drug-sensitive traces are
similar. The averaged TTX-sensitive ramp current reaches a peak value of –181  40 pA at –10.4  4.3 mV (n  6). The averaged
baclofen-sensitive ramp current reaches a peak value of –193  77 pA at –15.2  5.1 mV (n  6). E, F, Prior treatment with TTX does
eliminate the effect of baclofen and vice versa, suggesting that both agents eliminate the same current. Representative I-V plots show
that neither inward sodium current nor outward potassium current is further reduced by the other agent after exposure to one of the
agents. Cultured rat mitral cells were first treated with 0.2 M TTX or 10 M baclofen for 10 min, then with coapplication of 0.2 M
TTX or 10 M baclofen, respectively, for another 5 min. Application of 10 M baclofen in the presence of 0.2 M TTX does not
significantly reduce outward current (4.3  2.1%, n  4, p 
 0.05), nor does coapplication of 0.2 M TTX in the presence of 10 M
baclofen (2.2  1.0%, n  5, p 
 0.05).
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sults in channels that have only weak voltage sensitivity
and therefore can open and participate in membrane
electrical events over a wide voltage range. These chan-
nels are actively expressed in the cell bodies of neurons
from all over the brain (Egan et al., 1992a). The cell bodies
of mitral cells of the olfactory bulb are packed with
sodium-activated potassium channels (100% of patches
pulled from the cell body have KNa channels) and appear
to be a major determinant of the intrinsic excitability of
these cells. As in many mammalian neurons, the cell body
is interposed between the distal dendritic inputs (the
“tufts” in mitral cells) and the axon initial segment, which
is a site of action potential initiation and therefore the
output of the cell. If all KNa channels in the cell body were
constitutively active, incoming synaptic potentials would
easily be shunted and greatly diminished by the high K
conductance of the soma, and never reach the axon spike
initiation zone. This strategic placement of the channels
could be one plausible reason for a mechanism of neuro-
modulation of the channels. Thus, if KNa channels are
down-regulated by metabotropic signaling at the soma in
mitral and other output neurons, integrated synaptic po-
tentials would be able to pass through the cell body to the
spike initiation zone and generate an outgoing action poten-
tial. Hence, GABA acting on GABA-B receptors, which in
turn act on voltage-gated sodium channels, which in turn act
on sodium-activated potassium channels (all abundantly ex-
pressed on mitral cell bodies), would serve to modulate
synaptic effectiveness in this cell type. Additionally, how-
ever, GABA signaling through GABA-A receptors as well
as other GABA-B mechanisms of action are undoubtedly
present in the mammalian olfactory bulb and appear to be
involved in complex dendrodendritic interactions under-
gone by the lateral dendrites of mitral cells and the den-
drites of interacting granule cells (Isaacson and Vitten,
2003). However, it might be noted in this context that
GABA-B receptors are more sensitive to endogenous
GABA compared with GABA-A (Sodickson and Bean,
1996).
Multifaceted neuromodulatory control of KNa
channels
The neuromodulatory control of KNa channels is appar-
ently multifaceted and complex. It was shown in a heter-
ologous expression system that KNa channels can be
directly modulated by metabotropic signaling through the
G-q signaling pathway (Santi et al., 2006). However, the
coupling of the activity of KNa channels to the persistent
sodium current creates additional possibilities for modulat-
ing KNa channels, and this appears to be the mechanism by
which the GABA-B systemmodulates it. A previous report of
sodium channel modulation by direct G protein  activity
shows an enhancement of persistent sodium current rather
than a diminution (Mantegazza et al., 2005). Our findings,
however, suggest a neuromodulatory pathway of down-
regulation of the persistent sodium current. GABA-B is
reported to signal via the Gi-coupled GPCR pathway
(Bettler et al., 2004). However, the signaling pathways of
GABA-B receptors are complex and not yet fully resolved.
GABA-B signaling pathways are known to be highly vari-
able and are known to interact with a variety of other
signaling pathways (Thompson and Gahwiler, 1992;
Neves et al., 2002; Karls and Mynlieff, 2015). Thus the
mechanism of GABA-B signaling to reduce persistent
sodium current remains to be investigated. Nonetheless,
our finding—a functional relationship between widely dis-
tributed GABA-B receptors (Prosser et al., 2001; Schuler
Figure 4. Baclofen has no direct effect on SLO2.1 channels.
A, Whole-cell currents of SLO2.1 channels expressed in Xeno-
pus oocytes before (control) and after the addition of 10 M
baclofen. The currents were evoked by voltage pulses from –100
to 40 mV in 10-mV steps at a holding potential of –80 mV.
B, Representative I-V plot of currents from A shows that
baclofen has no direct effect on SLO2.1 currents. Plot in C
summarizes the current measurements at 40 mV before (control)
and after baclofen treatment. Current values were normalized by
control. Mean value (black horizontal line) and SD error bar are
shown. There is no significant change in current amplitude after
baclofen treatment (n  5, p 
 0.05).
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et al., 2001; Bettler et al., 2004) and widely distributed
sodium-activated potassium channels (Egan et al., 1992a, b;
Bhattacharjee and Kaczmarek, 2005)—suggests that we
may have revealed a significant functional mechanism for
GABA-B neuromodulation.
Does the effect of GABA-B activation have a net
positive or inhibitory effect on excitability?
The interrelatedness of INaP and IKNa suggests new
ways that neurons may tune their excitability, and our
finding that this system is controlled through the GABA-B
pathway presents new insights for controlling cell excit-
ability through GABA-B modulators. Whether these two
interacting currents have a net excitatory or inhibitory
effect depends on the amplitudes and balance of the two
currents in a particular neuronal type. INaP/IKNa coupling
is a negative feedback system; INaP is excitatory and IKNa
is inhibitory to cell electrical activity. GABA-B activation
could have a net excitatory effect in neurons such as
mitral cells in which IKNa is a large component of the
outward current; inhibition of a small inward persistent
sodium current may inhibit a much larger potassium cur-
rent, producing a net inhibitory effect.
Currently the only FDA-approved drug to target (acti-
vate) the GABA-B receptor is baclofen, which is used to
treat muscle spasticity disorders. However, baclofen has
many undesirable side effects that could arise from an
unintentional excitatory effect (Vergnes et al., 1997; Bowery,
2006). Nevertheless, GABA-B activators and inhibitors
could be highly useful agents to treat many neurologic
disorders once a more detailed understanding of the
physiologic and molecular basis of GABA-B signaling and
downstream effector molecules is acquired. It is hoped
that the work presented here will aid in the understanding
and design of GABA-B modulators that could be helpful
and resourceful pharmacological agents.
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